A comprehensive analysis of dementia cerebrospinal fluid biomarkers using GWAs, polygenic risk scores and Mendelian randomization in Parkinson’s disease
2011 ◽
Vol 17
(1)
◽
pp. 61-64
◽
2017 ◽
Vol 17
(8)
◽
pp. 771-780
◽
2017 ◽
pp. 275-294
◽
2015 ◽
Vol 21
(7)
◽
pp. 758-764
◽
2012 ◽
Vol 34
(7)
◽
pp. 669-676
◽